DIABETES WORSENS PERIODONTITIS; SEVERE PERIODONTITIS CAN WORSEN GLYCEMIC CONTROL.

ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1308 DIABETES WORSENS PERIODONTITIS; SEVERE PERIODONTITIS CAN WORSEN GLYCEMIC CONTROL. Muhitdinova F.G’. Tashkent State Medical University Abstract Chronic periodontitis is a multifactorial inflammatory disease characterized by progressive destruction of periodontal tissues and alveolar bone. Although microbial biofilm is the primary etiological factor, tissue damage largely depends on the host immune-inflammatory response. Proinflammatory cytokines play a central role in mediating periodontal inflammation, connective tissue degradation, and bone resorption. The aim of this study was to analyze the role of key pro-inflammatory cytokines in the pathogenesis of chronic periodontitis based on clinical, microbiological, and molecular-genetic evidence, with particular emphasis on TNF-α and IL-1β. The review integrates data from clinical observations, microbiological findings, and genetic association studies evaluating cytokine activity and gene polymorphisms related to periodontal disease. Special attention is given to single nucleotide polymorphisms of TNF-α and IL-1β genes and their association with disease susceptibility and severity. Accumulating evidence indicates that elevated expression of pro-inflammatory cytokines contributes to periodontal tissue destruction by enhancing leukocyte recruitment, matrix metalloproteinase activation, and osteoclastogenesis. Genetic polymorphisms affecting cytokine regulation may amplify inflammatory responses and predispose individuals to more aggressive forms of chronic periodontitis. Understanding cytokine-mediated mechanisms provides a biological basis for personalized periodontal diagnostics and targeted therapeutic strategies. Integration of clinical and genetic markers may improve risk assessment, early diagnosis, and treatment outcomes in periodontal practice. Keywords chronic periodontitis; cytokines; TNF-α; IL-1β; inflammation; genetic susceptibility; periodontal pathogenesis 1. Introduction Chronic periodontitis is one of the most prevalent inflammatory diseases affecting the oral cavity and remains a leading cause of tooth loss worldwide. The disease is initiated by dental plaque biofilm; however, the severity of periodontal tissue destruction varies significantly among individuals exposed to similar microbial challenges. This heterogeneity highlights the importance of host-related factors, particularly immuneinflammatory mechanisms, in disease pathogenesis. Among these mechanisms, pro-inflammatory cytokines are recognized as key regulators of periodontal inflammation and tissue breakdown. Cytokines orchestrate the host response to microbial challenge by modulating leukocyte migration, vascular permeability, extracellular matrix degradation, and bone metabolism. Dysregulation of ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1309 cytokine production may result in excessive inflammatory responses and irreversible periodontal damage. Recent advances in molecular genetics have revealed that genetic polymorphisms in cytokineencoding genes can influence cytokine expression levels and biological activity. These genetic variations may partly explain individual susceptibility to chronic periodontitis and differences in disease severity. The present article reviews clinical and genetic evidence regarding the role of pro-inflammatory cytokines in chronic periodontitis pathogenesis and discusses their relevance for personalized periodontal care. 2. Pro-Inflammatory Cytokines in Periodontal Inflammation Pro-inflammatory cytokines are small signaling proteins produced by immune and resident cells in response to microbial stimuli. In periodontal tissues, cytokines are released by macrophages, neutrophils, fibroblasts, and epithelial cells following bacterial challenge. Among the numerous cytokines involved in periodontal inflammation, TNF-α and IL-1β are considered pivotal mediators. These cytokines initiate and amplify inflammatory cascades, promote recruitment of inflammatory cells, and stimulate the production of matrix metalloproteinases responsible for connective tissue degradation. Elevated levels of TNF-α and IL-1β have been consistently detected in gingival crevicular fluid and periodontal tissues of patients with chronic periodontitis. Their concentrations correlate with disease activity and severity, underscoring their pathogenic significance. 3. TNF-α in Periodontal Tissue Destruction Tumor necrosis factor-alpha is a potent pro-inflammatory cytokine involved in immune regulation and bone metabolism. In periodontal tissues, TNF-α enhances the expression of adhesion molecules, facilitates leukocyte migration, and stimulates osteoclast differentiation. TNF-α promotes alveolar bone resorption by activating receptor activator of nuclear factor kappa-B ligand (RANKL) signaling and suppressing osteoprotegerin expression. This imbalance favors osteoclastogenesis and accelerates bone loss. Clinical studies have demonstrated a positive association between TNF-α levels and the severity of periodontal destruction. Moreover, polymorphic variants of the TNF-α gene may influence transcriptional activity and cytokine production, thereby modulating individual inflammatory responses. 4. IL-1β and Its Role in Periodontal Pathogenesis Interleukin-1 beta is another key mediator of periodontal inflammation. IL-1β induces the production of prostaglandins and matrix metalloproteinases and enhances bone resorption by stimulating osteoclast activity. Increased IL-1β expression has been observed in periodontal lesions and is associated with clinical attachment loss and alveolar bone destruction. Genetic polymorphisms within the IL-1β gene cluster have been linked to variations in cytokine production and disease susceptibility. Certain IL-1β gene variants are associated with more severe periodontal inflammation and accelerated disease progression, suggesting a genetic contribution to host response variability. 5. Genetic Polymorphisms and Cytokine Regulation ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1310 Single nucleotide polymorphisms in cytokine genes may alter promoter activity, mRNA stability, or protein function. As a result, individuals carrying unfavorable genetic variants may exhibit heightened inflammatory responses to periodontal pathogens. Genetic association studies have identified polymorphisms in TNF-α and IL-1β genes that correlate with increased risk and severity of chronic periodontitis. Combined unfavorable genotypes may exert a cumulative effect, amplifying inflammatory signaling and tissue destruction. These findings support the concept that chronic periodontitis is not solely a microbial disease but also a genetically modulated inflammatory condition. 6. Clinical Implications and Personalized Periodontal Care Understanding cytokine-mediated mechanisms in periodontal pathogenesis has important clinical implications. Identification of genetic and inflammatory markers may enable early detection of individuals at high risk for aggressive disease. Incorporating molecular-genetic data into periodontal diagnostics could support personalized preventive strategies, targeted anti-inflammatory therapies, and improved treatment planning. Such approaches align with the principles of precision medicine and personalized dentistry. 7. Conclusions Pro-inflammatory cytokines, particularly TNF-α and IL-1β, play a central role in the pathogenesis of chronic periodontitis by regulating inflammatory responses and bone resorption. Genetic polymorphisms affecting cytokine regulation contribute to individual susceptibility and disease severity. Integration of clinical, microbiological, and genetic evidence provides a comprehensive understanding of periodontal disease mechanisms and offers new perspectives for personalized periodontal care. References 1. Budtz-Jørgensen, E.; Lombardi, T. Denture stomatitis revisited. Periodontology 2000 2018, 78, 254–261. 2. Felton, D.A. Complete edentulism and comorbid diseases: An update. Journal of Prosthodontics 2016, 25, 5–20. 3. Grigoriadou, M.E.; Koutayas, S.O.; Madianos, P.N.; Strub, J.R. Interleukin-1 as a genetic marker for periodontal disease. Journal of Clinical Periodontology 2010, 37, 517–523. 4. Napimoga, M.H.; Nunes, L.H.; Maciel, A.A.; et al. Possible involvement of IL-1β polymorphism in chronic periodontitis. Journal of Oral Science 2014, 56, 13–19. 5. Tian, Y.; Feng, P.; Wang, Y.; et al. Association between TNF-α gene polymorphism and chronic periodontitis: A meta-analysis. Journal of Periodontal Research 2013, 48, 298–305. 6. Ayazi, G.; Pirayesh, M. Genetic polymorphisms of cytokines and susceptibility to periodontal disease. Journal of Dental Research, Dental Clinics, Dental Prospects 2013, 7, 8–15. 7. Feng, P.; Tian, Y.; Chen, Z.; et al. Association of TNF-α polymorphisms with periodontal disease risk: Evidence from a population-based study. Inflammation Research 2014, 63, 901–908. 8. Casado, P.L.; Villas-Boas, R.; de Mello, W.; et al. Genetic susceptibility in chronic periodontitis: A systematic review. Journal of Periodontology 2015, 86, 99–111. 9. Petrin, A.N.; Tsarev, V.N. Cytokine gene polymorphisms in inflammatory diseases: Clinical significance. Infection and Immunity 2011, 79, 3381–3389. ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1311 10. Gulmukhamedov, P.B. Clinical and molecular-genetic aspects of periodontitis pathogenesis. PhD Thesis Abstract, Tashkent State Dental Institute, Tashkent, Uzbekistan, 2019. 11. Hasanov, L.E.; Abdullaeva, N.R.; Mirkhoshimova, M.F. Genetic markers of periodontal inflammation in Central Asian populations. Stomatologiya 2017, 1, 15–19. 12. Safarov, M.T.; Dadabaeva, M.U.; Asemova, S.A.; et al. Modern aspects of mathematic modeling in dental implantation. Science and Education: Problems and Prospects 2020, 354–359. 13. Xabilov, N.L.; Xabilov, B.N.; Sharipov, S.S.; et al. Plant-based complexes in dentistry. Journal of New Century Innovations 2024, 66, 203–209. 14. World Health Organization. Oral health fact sheet. WHO, Geneva, Switzerland, 2012. Available online: https://www.who.int (accessed on Day Month Year)